Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Isogawa

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 12, 2004
Reduced anxious behavior in mice lacking the CCK2 receptor geneYukiko Horinouchi, Jotaro Akiyoshi, Aki Nagata, et al.
Neuropeptides|September 5, 2007
Administration of antisense DNA for hepatocyte growth factor causes an depressive and anxiogenic response in ratsMasatoshi Wakatsuki, Jotaro Akiyoshi, Shugo Ichioka, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 24, 2006
Administration of antisense DNA for ghrelin causes an antidepressant and anxiolytic response in ratsMasayuki Kanehisa, Jotaro Akiyoshi, Tomoko Kitaichi, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 20, 2012
Aripiprazole augmentation in 13 patients with refractory obsessive-compulsive disorder: a case seriesHaruka Higuma, Masayuki Kanehisa, Yoshihiro Maruyama, et al.
Neuropsychobiology|June 9, 2007
Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorderTakatoshi Hikichi, Jotaro Akiyoshi, Shugo Ichioka, et al.
Neuroscience Research|December 24, 2011
Administration of antisense DNA for GPR39-1b causes anxiolytic-like responses and appetite loss in ratsYoshinobu Ishitobi, Jotaro Akiyoshi, Shuhei Honda, et al.
Biological Psychology|March 25, 2008
Social support and enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests in patients with major depressive disorderJusen Tsuru, Jotaro Akiyoshi, Yoshihiro Tanaka, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 3, 2012
Association of CRHR1 and CRHR2 with major depressive disorder and panic disorder in a Japanese populationYoshinobu Ishitobi, Shinya Nakayama, Kana Yamaguchi, et al.
Neuro Endocrinology Letters|August 8, 2013
The thyrotropin-releasing hormone test may predict recurrence of clinical depression within ten years after dischargeJusen Tsuru, Yoshinobu Ishitobi, Taiga Ninomiya, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 9, 2011
Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patientsYoshihiro Tanaka, Yoshinobu Ishitobi, Yoshihiro Maruyama, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 12, 2004
Reduced anxious behavior in mice lacking the CCK2 receptor geneYukiko Horinouchi, Jotaro Akiyoshi, Aki Nagata, et al.
Neuropeptides|September 5, 2007
Administration of antisense DNA for hepatocyte growth factor causes an depressive and anxiogenic response in ratsMasatoshi Wakatsuki, Jotaro Akiyoshi, Shugo Ichioka, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 24, 2006
Administration of antisense DNA for ghrelin causes an antidepressant and anxiolytic response in ratsMasayuki Kanehisa, Jotaro Akiyoshi, Tomoko Kitaichi, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 20, 2012
Aripiprazole augmentation in 13 patients with refractory obsessive-compulsive disorder: a case seriesHaruka Higuma, Masayuki Kanehisa, Yoshihiro Maruyama, et al.
Neuropsychobiology|June 9, 2007
Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorderTakatoshi Hikichi, Jotaro Akiyoshi, Shugo Ichioka, et al.
Neuroscience Research|December 24, 2011
Administration of antisense DNA for GPR39-1b causes anxiolytic-like responses and appetite loss in ratsYoshinobu Ishitobi, Jotaro Akiyoshi, Shuhei Honda, et al.
Biological Psychology|March 25, 2008
Social support and enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests in patients with major depressive disorderJusen Tsuru, Jotaro Akiyoshi, Yoshihiro Tanaka, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 3, 2012
Association of CRHR1 and CRHR2 with major depressive disorder and panic disorder in a Japanese populationYoshinobu Ishitobi, Shinya Nakayama, Kana Yamaguchi, et al.
Neuro Endocrinology Letters|August 8, 2013
The thyrotropin-releasing hormone test may predict recurrence of clinical depression within ten years after dischargeJusen Tsuru, Yoshinobu Ishitobi, Taiga Ninomiya, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 9, 2011
Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patientsYoshihiro Tanaka, Yoshinobu Ishitobi, Yoshihiro Maruyama, et al.
Pageof 3